LINDSAY HANDLEY: Open Payments
NPI 1912418005 · CORDOVA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 58 payments from 9 companies in 2025. Trend: 2023 $43 · 2024 $0 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $529 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Novo Nordisk Inc | 5 | $120 |
| Dexcom, Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Boston Scientific Corporation | 1 | $24 |
| Corcept Therapeutics | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, Ozempic, AIRSUPRA, Dexcom G6 Transmitter, UBRELVY, MOUNJARO, XIFAXAN, Patient Trial Kit.
Industry payments across AL — which companies pay providers there.
